Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM
-
Number of holders
-
100
-
Total 13F shares, excl. options
-
6,858,066
-
Shares change
-
+362,200
-
Total reported value, excl. options
-
$728,037,586
-
Value change
-
+$103,092,138
-
Put/Call ratio
-
781%
-
Number of buys
-
55
-
Number of sells
-
-73
-
Price
-
$106.18
Significant Holders of FURIEX PHARMACEUTICALS INC - COM (FURX) as of Q2 2014
157 filings reported holding FURX - FURIEX PHARMACEUTICALS INC - COM as of Q2 2014.
FURIEX PHARMACEUTICALS INC - COM (FURX) has 100 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,858,066 shares
.
Largest 10 shareholders include D. E. Shaw & Co., Inc. (804,024 shares), AQR CAPITAL MANAGEMENT LLC (745,469 shares), Magnetar Financial LLC (734,006 shares), MORGAN STANLEY (672,384 shares), OXFORD ASSET MANAGEMENT (378,901 shares), ARROWGRASS CAPITAL PARTNERS (US) LP (251,319 shares), BlackRock Institutional Trust Company, N.A. (243,580 shares), VANGUARD GROUP INC (236,100 shares), JPMORGAN CHASE & CO (232,991 shares), and BlackRock Fund Advisors (221,068 shares).
This table shows the top 100 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.